APA (7th ed.) Citation

Tungjitviboonkun, S., Bumrungratanayos, N., Jitwimungsanon, J., Kheamakulvanich, T., & Siramongkholkarn, S. (2024). Efficacy and safety of fostamatinib in refractory immune thrombocytopenia. Annals of Hematology, 103(9), 3357. https://doi.org/10.1007/s00277-024-05824-7

Chicago Style (17th ed.) Citation

Tungjitviboonkun, Songphol, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon, Thanat Kheamakulvanich, and Smuch Siramongkholkarn. "Efficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia." Annals of Hematology 103, no. 9 (2024): 3357. https://doi.org/10.1007/s00277-024-05824-7.

MLA (9th ed.) Citation

Tungjitviboonkun, Songphol, et al. "Efficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia." Annals of Hematology, vol. 103, no. 9, 2024, p. 3357, https://doi.org/10.1007/s00277-024-05824-7.